The immunology of Epstein-Barr virus infection

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
D J MossR Khanna

Abstract

Epstein-Barr virus is a classic example of a persistent human virus that has caught the imagination of immunologists, virologists and oncologists because of the juxtaposition of a number of important properties. First, the ability of the virus to immortalize B lymphocytes in vitro has provided an antigen presenting cell in which all the latent antigens of the virus are displayed and are available for systematic study. Second, the virus presents an ideal system for studying the immune parameters that maintain latency and the consequences of disturbing this cell-virus relationship. Third, this wealth of immunological background has provided a platform for elucidating the role of the immune system in protection from viral-associated malignancies of B cell and epithelial cell origin. Finally, attention is now being directed towards the development of vaccine formulations which might have broad application in the control of human malignancies.

References

Apr 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·E Svedmyr, M Jondal
Jan 15, 1976·International Journal of Cancer. Journal International Du Cancer·G Henle, W Henle
May 15, 1979·International Journal of Cancer. Journal International Du Cancer·A B RickinsonJ H Pope
Jan 1, 1992·Vaccine·A J Morgan
Jan 1, 1992·European Journal of Immunology·A ApolloniT Sculley
Nov 11, 1991·International Journal of Cancer. Journal International Du Cancer·S PothenG R Pearson
Jan 1, 1990·The Journal of Experimental Medicine·S R BurrowsD J Moss
Sep 1, 1990·The Journal of Infectious Diseases·T B SculleyD A Cooper
Mar 1, 1990·Immunology Today·R I LechlerF H Bach
Aug 1, 1990·Immunology Today·C E SharrockS Man
Sep 30, 1989·Lancet·J W SixbeyL Resnick
Jan 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·W HenleS E Straus
Sep 1, 1974·The Journal of Infectious Diseases·G HenieC A Horwitz
May 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·G J HoffmanS D Hayward
Jul 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·I S MiskoJ H Pope
Sep 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·D A Thorley-Lawson, K Geilinger
Jun 1, 1981·Immunology Letters·I S MiskoJ H Pope
Sep 15, 1983·International Journal of Cancer. Journal International Du Cancer·D J MossN Kunaratnam
Feb 15, 1984·International Journal of Cancer. Journal International Du Cancer·I S MiskoR G Kane
Sep 1, 1994·The Journal of General Virology·S R BurrowsA Suhrbier
Jun 20, 1995·Proceedings of the National Academy of Sciences of the United States of America·S A ThomsonA Suhrbier
Sep 1, 1995·Microbiological Reviews·R KhannaD J Moss
Mar 1, 1995·Human Pathology·H J HarnW H Lee
Jan 5, 1995·The New England Journal of Medicine·S D Blatt, V Meguid

❮ Previous
Next ❯

Citations

Dec 7, 2002·Critical Reviews in Oncology/hematology·Shouichi OhgaToshiro Hara
Feb 9, 2011·Immunology and Cell Biology·John J MilesDavid A Price
Feb 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Irene GörzerJan J Cornelissen
Nov 5, 2002·Annual Review of Immunology·Phillip Wong, Eric G Pamer
Mar 23, 2004·Annual Review of Immunology·Raymond M WelshEva Szomolanyi-Tsuda
Mar 23, 2006·Annual Review of Immunology·Markus G RudolphIan A Wilson
Oct 3, 2007·The Journal of Clinical Investigation·Karen A McAulayDorothy H Crawford
Jul 10, 2004·Trends in Molecular Medicine·Wolfgang Hammerschmidt, Bill Sugden
Jun 26, 2003·Internal Medicine Journal·G Ada
Aug 15, 2002·British Medical Bulletin·M R WillsJ G P Sissons
Jul 3, 2002·Nature Reviews. Immunology·Raymond M Welsh, Liisa K Selin
Dec 2, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Inge E A FleschDavid C Tscharke
Jul 19, 2019·Journal of Clinical Pathology·Jonathan R Kerr
Nov 13, 2004·The Journal of Biological Chemistry·Maria Teresa FiorilloBarbara Uchanska-Ziegler
Dec 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Simone GuggemoosHeiko Adler
May 16, 2013·Current Opinion in Rheumatology·Barbara Uchanska-ZieglerPeter Schmieder
Mar 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Haiyan LiuPeter C Doherty
Oct 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lars Kjer-NielsenJamie Rossjohn
Nov 30, 2015·Indian Pediatrics·Madhuravasal Krishnan JananiHajib N Madhavan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.